Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04189445
Title Futibatinib in Patients With Specific FGFR Aberrations
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | TUR | SWE | NLD | ITA | GBR | FRA | ESP | DEU | BEL

Additional content available in CKB BOOST